medline.ch Onkologie Gynäkologische Tumoren

	Real-Time Integration of Patient-Reported Outcomes in Breast Cancer Surgery: Feasibility of the BREAST-Q REACT. Plast Reconstr Surg Gabay AJ, Abu El Hawa A, Boe L, Dinh-Do D, Rakauskas A, Kim M, Stern CS, Mehrara BJ, Tadros A, Nelson JA. PMID: 42430729 [PubMed - as supplied by publisher]
	Applications of Large Language Models in Ovarian Cancer Management: Protocol for a Systematic Review and Meta-Analysis. JMIR Res Protoc Wang Y, Yao J, Tian J, Wang Y, Yang Y. PMID: 42430510 [PubMed - indexed for MEDLINE]
	Understanding barriers and facilitators to cervical cancer prevention among young Korean Women: A focus group interview study. PLoS One Kim HJ, Lee HJ, Shin HY, Lee HS, Jun JK, Choi KS, Suh M. PMID: 42430333 [PubMed - indexed for MEDLINE]
	Establishing a Multimodal Model for Predicting Lymphovascular Invasion in Breast Cancer Using Deep Transfer Learning Based on Ultrasound and Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Oncol Res Treat He M, Zhu F, Jiang F, Liu Y, Guo Y, Yang Y, Jiang H, Xiong F, Cheng W, Xu Z, Liu B. PMID: 42430299 [PubMed - as supplied by publisher]
	Population-Level Outcomes for Screening Program Cancers in First Nations People in Ontario, Canada. JAMA Netw Open Sheppard AJ, Sutradhar R, Liu N, Kewayosh A, Leylachian S, Senese L, Ianni A, Hyett S, Chiarelli AM, Kupets R, Tammemägi CM, Tinmouth J. PMID: 42430169 [PubMed - indexed for MEDLINE]
	Early first-line systemic anticancer therapeutic attrition after metastatic recurrence in triple-negative breast cancer following neoadjuvant chemo-immunotherapy: a multicenter real-world study. Breast Cancer Res Treat Fedele P, Rizzo A, Landriscina M, Stucci LS, Inneo C, Morritti M, Morelli F, Giuliani F, Moraca L, Cairo G, Giampaglia M, Tedesco B, Melaccio A, Maselli FM, Gnoni A, Licchetta A, Fumai F, Vitale E, Marino FR, Zifarone E, Lanotte L, Ardito R, Gadaleta-Caldarola G. PMID: 42430019 [PubMed - indexed for MEDLINE]
	Breast cancer screening adherence after multigene panel testing among women with pathogenic variants in moderate-risk genes or with empirically increased breast cancer risk. Breast Cancer Res Treat Comeaux JG, Gutierrez N, Ricker CN, Nie Q, Nguyen A, Garcia I, Chang EY, Waggoner RM, Groshen S, Lerman C, Spicer D, Culver JO. PMID: 42430009 [PubMed - indexed for MEDLINE]
	Retinoic acid disrupts cumulus granulosa cells function via EGFR downregulation: induction of PCOS and infertility in adult female mice. Histochem Cell Biol Said A, Marzouk M, Mahmoud A, Emad M, Elkhbery M, Alwutayd KM, Alkhateeb MA, Aldawsari MA, Shokry AE, AbdElkhalek AS. PMID: 42429978 [PubMed - indexed for MEDLINE]
	EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study. Breast Cancer Res Treat Martins-Branco D, Lobo-Martins S, Aftimos P, Pereira B, Vasconcelos de Matos L, Fernandes L, Campôa E, Nader-Marta G, Moreau M, Taylor D, Duhoux FP, Simões P, Garcia AR, Patel V, Confente C, Alpuim Costa D, Pereira J, Santos C, Paesmans M, Sarmento F, Gantes Padrão T, Simão D, Bandarra D, Sousa B, Brito M, Gombos A, Ameye L, de Azambuja E. PMID: 42429895 [PubMed - indexed for MEDLINE]
	Impact of trop-2 expression on the efficacy of trop-2-targeted antibody-drug conjugates in metastatic breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst Buonaiuto R, Pagliuca M, Longobardi A, Cataldo ML, Arecco L, Gerosa R, Gentile G, Caltavituro A, Barone I, Karakose B, Agostinetto E, Sotiriou C, De Laurentiis M, De Azambuja E, De Angelis C. PMID: 42429566 [PubMed - as supplied by publisher]
	p16/Ki-67 dual-stain immunocytochemistry in precision cervical cancer prevention: immunoprofile and clinical decision-making. Pol J Pathol Trzeszcz M, Jach R. PMID: 42429429 [PubMed - indexed for MEDLINE]
	Immunohistochemical and molecular diagnostics tailoring personalised ovarian cancer therapy. Pol J Pathol Kowalewski AM, Szylberg . PMID: 42429424 [PubMed - indexed for MEDLINE]
	New and emerging entities ofÂ uterine mesenchymal tumours in theÂ era ofÂ molecular testing. Pol J Pathol Dundr P, Kendall Bárt, Hojný J, Mat, N. PMID: 42429422 [PubMed - indexed for MEDLINE]
	Breast Cancer Presentation, Treatment Patterns, and Progression-Free Survival at a Tertiary Oncology Centre in Bangladesh: A Retrospective Study. Cancer Rep (Hoboken) Chowdhury Q, Rahman MA, Begum FA, Shiddika A, Nurunnabi M, Rupa SA, Parvez M, Begum SMKN, Sultana S. PMID: 42429366 [PubMed - indexed for MEDLINE]
	Data-augmented multistate modeling for chronic disease processes using cross-sectional studies: application to HPV and cervical precancer. Biostatistics Mao F, Campos NG, Cheung LC. PMID: 42429185 [PubMed - indexed for MEDLINE]
	Combined Contrast Enhanced Mammography and Digital Breast Tomosynthesis in Patients Suspected of Having Breast Cancer: A Prospective Comparison With Digital Mammography and Breast MRI-Findings of the CONTEST Study. J Med Imaging Radiat Oncol Savaridas SL, Ali K, Vinnicombe S, Rauchhaus P, Evans AJ, Sharma N, Bolt S, Whelehan P. PMID: 42429012 [PubMed - as supplied by publisher]
	Effectiveness of a Smartphone-Based Self-Management App (BeHealth app) for Women with Breast Cancer: A Randomized Controlled Trial. Iran J Public Health Kim HS, Kim HJ. PMID: 42428742 [PubMed]
	Cost-effectiveness analysis of pyrotinib combined with trastuzumab and docetaxel as first-line treatment for HER2-positive metastatic breast cancer in China. Front Pharmacol Liang M, Liu S, Zhang X, Liu Q. PMID: 42428506 [PubMed]
	Treatment of recurrent low grade serous ovarian cancer: MEK inhibition and the RAMP 201 trial. Gynecol Pelvic Med Ali M, Brooks R. PMID: 42428456 [PubMed]
	Uterine fibroids reduce the sensitivity of ultrasound to detect endometrioid and serous endometrial cancer: a retrospective cohort study. Gynecol Pelvic Med Najor AJ, Aspir TB, Fife AJ, Tagoe UJ, Hussein NM, Moran ST, Grant KR, Isani SS, Cowan MW, Nevadunsky NS, Rotenberg OD, Lin KY. PMID: 42428452 [PubMed]

Artikel 1 - 20 / 331937

Seite 1 von 16597

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung